1-4 of 4
Elicia Peneul
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fixed-duration subcutaneous mosunetuzumab continues to demonstrate high rates of durable responses in patients with relapsed/refractory follicular lymphoma after ≥2 prior therapies: 3-year follow-up from a pivotal Phase II study

Free
Sarit Assouline, Nancy Bartlett, Laurie Sehn, Pratyush Giri, John Kuruvilla, Stephen Schuster, Sung-Soo Yoon, Keith Fay, Georg Hess, Martin Dreyling, Norma Gutiérrez, Eva Cybulski, Fidelis Sabalvaro, Elicia Peneul, Samuel Tracy, Denison Kuruvilla, Joseph Chen, Volker Wiebking, Michael C. Wei, Elizabeth Budde
Journal: Blood
Blood (2025) 146 (Supplement 1): 5353.
https://doi.org/10.1182/blood-2025-5353
Published: 2025
Journal Articles

Fixed treatment duration mosunetuzumab continues to demonstrate clinically meaningful outcomes in patients with relapsed/refractory (R/R) follicular lymphoma (FL) after ≥2 prior therapies: 5-year follow-up of a pivotal Phase II study

Free
Elizabeth Budde, Laurie Sehn, Matthew Matasar, Stephen Schuster, Sarit Assouline, John Kuruvilla, Won-Seog Kim, Chan Cheah, Mazyar Shadman, Sascha Dietrich, Matthew Ku, Dima El-Sharkawi, Norma Gutiérrez, Michael C. Wei, Shen Yin, Jason Sit, Samuel Tracy, Fidelis Sabalvaro, Elicia Peneul, Nancy Bartlett
Journal: Blood
Blood (2025) 146 (Supplement 1): 5352.
https://doi.org/10.1182/blood-2025-5352
Published: 2025
Journal Articles

Long-term follow-up with sustained progression-free survival (PFS) benefit after subcutaneous (SC) mosunetuzumab in combination with polatuzumab vedotin compared with rituximab plus polatuzumab vedotin in patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma

Free
Nilanjan Ghosh, Julio Chavez, Mariana Bastos-Oreiro, Catherine Diefenbach, Izidore S. Lossos, Nirav Shah, Sarit Assouline, Adam Olszewski, Seema Naik, Song Pham, Michael C. Wei, Connie L. Batlevi, Iris To, Wahib S. Ead, Sneha Makadia, Elicia Peneul, Elizabeth Budde
Journal: Blood
Blood (2025) 146 (Supplement 1): 1020.
https://doi.org/10.1182/blood-2025-1020
Published: 2025
Journal Articles

Fixed-duration intravenous mosunetuzumab plus polatuzumab vedotin combination therapy continues to demonstrate durable responses in patients with large B-cell lymphoma: 3-year follow-up from a Phase Ib/II study

Free
Manali Kamdar, Julio Chavez, Adam Olszewski, Sarit Assouline, Izidore S. Lossos, Catherine Diefenbach, Dipenkumar Modi, Waleed Sabry, Seema Naik, Amitkumar Mehta, Sneha Makadia, Song Pham, Elicia Peneul, Hao Wu, Wahib S. Ead, Iris To, Dennis J. Houston, Connie Lee Batlevi, Elizabeth Budde
Journal: Blood
Blood (2025) 146 (Supplement 1): 3735.
https://doi.org/10.1182/blood-2025-3735
Published: 2025